• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于影响函数的限制平均生存时间的综合检验。

Omnibus test for restricted mean survival time based on influence function.

机构信息

Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, USA.

School of Mathematics and Statistics, Beijing Institute of Technology, Beijing, China.

出版信息

Stat Methods Med Res. 2023 Jun;32(6):1082-1099. doi: 10.1177/09622802231158735. Epub 2023 Apr 4.

DOI:10.1177/09622802231158735
PMID:37015346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10331519/
Abstract

The restricted mean survival time (RMST), which evaluates the expected survival time up to a pre-specified time point , has been widely used to summarize the survival distribution due to its robustness and straightforward interpretation. In comparative studies with time-to-event data, the RMST-based test has been utilized as an alternative to the classic log-rank test because the power of the log-rank test deteriorates when the proportional hazards assumption is violated. To overcome the challenge of selecting an appropriate time point , we develop an RMST-based omnibus Wald test to detect the survival difference between two groups throughout the study follow-up period. Treating a vector of RMSTs at multiple quantile-based time points as a statistical functional, we construct a Wald test statistic and derive its asymptotic distribution using the influence function. We further propose a new procedure based on the influence function to estimate the asymptotic covariance matrix in contrast to the usual bootstrap method. Simulations under different scenarios validate the size of our RMST-based omnibus test and demonstrate its advantage over the existing tests in power, especially when the true survival functions cross within the study follow-up period. For illustration, the proposed test is applied to two real datasets, which demonstrate its power and applicability in various situations.

摘要

限制平均生存时间(RMST),用于评估特定时间点之前的预期生存时间,由于其稳健性和直接的解释,已被广泛用于总结生存分布。在具有生存时间数据的比较研究中,基于 RMST 的检验已被用作经典对数秩检验的替代方法,因为当比例风险假设被违反时,对数秩检验的功效会降低。为了克服选择适当时间点的挑战,我们开发了一种基于 RMST 的综合 Wald 检验,以检测整个研究随访期间两组之间的生存差异。将多个基于分位数的时间点的 RMST 向量视为统计函数,我们构建了 Wald 检验统计量,并使用影响函数推导出其渐近分布。我们进一步提出了一种基于影响函数的新方法来估计渐近协方差矩阵,而不是常用的自举方法。在不同场景下的模拟验证了我们基于 RMST 的综合检验的大小,并证明了它在功效方面优于现有检验,尤其是当真实生存函数在研究随访期间相交时。为了说明这一点,我们将提出的检验应用于两个真实数据集,展示了它在各种情况下的功效和适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade3/10331519/c181007586aa/10.1177_09622802231158735-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade3/10331519/187bb9f677ca/10.1177_09622802231158735-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade3/10331519/5e5b127ba6b6/10.1177_09622802231158735-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade3/10331519/b5b154ee16cd/10.1177_09622802231158735-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade3/10331519/211b778091eb/10.1177_09622802231158735-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade3/10331519/f5ab22f4bc05/10.1177_09622802231158735-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade3/10331519/c181007586aa/10.1177_09622802231158735-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade3/10331519/187bb9f677ca/10.1177_09622802231158735-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade3/10331519/5e5b127ba6b6/10.1177_09622802231158735-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade3/10331519/b5b154ee16cd/10.1177_09622802231158735-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade3/10331519/211b778091eb/10.1177_09622802231158735-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade3/10331519/f5ab22f4bc05/10.1177_09622802231158735-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade3/10331519/c181007586aa/10.1177_09622802231158735-fig6.jpg

相似文献

1
Omnibus test for restricted mean survival time based on influence function.基于影响函数的限制平均生存时间的综合检验。
Stat Methods Med Res. 2023 Jun;32(6):1082-1099. doi: 10.1177/09622802231158735. Epub 2023 Apr 4.
2
Designing clinical trials with (restricted) mean survival time endpoint: Practical considerations.设计(受限)平均生存时间终点的临床试验:实用考虑。
Clin Trials. 2020 Jun;17(3):285-294. doi: 10.1177/1740774520905563. Epub 2020 Feb 17.
3
[Application of restricted mean survival time in clinical follow-up study].受限平均生存时间在临床随访研究中的应用
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Feb 10;40(2):247-250. doi: 10.3760/cma.j.issn.0254-6450.2019.02.023.
4
Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time-to-event end point.在具有事件发生时间终点的优效性试验中,受限平均生存时间与风险比的比较。
Pharm Stat. 2018 May;17(3):202-213. doi: 10.1002/pst.1846. Epub 2017 Dec 28.
5
RMST-based multiple contrast tests in general factorial designs.基于 RMST 的多对比检验在一般析因设计中的应用。
Stat Med. 2024 May 10;43(10):1849-1866. doi: 10.1002/sim.10017. Epub 2024 Feb 25.
6
Dynamic RMST curves for survival analysis in clinical trials.用于临床试验生存分析的动态受限平均生存时间曲线
BMC Med Res Methodol. 2020 Aug 27;20(1):218. doi: 10.1186/s12874-020-01098-5.
7
Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology.肿瘤学中以时间为事件的当代 III 期随机对照试验中统计检验的经验功效比较。
Clin Trials. 2020 Dec;17(6):597-606. doi: 10.1177/1740774520940256. Epub 2020 Sep 15.
8
Restricted mean survival time as a summary measure of time-to-event outcome.限制平均生存时间作为时间事件结局的总结衡量指标。
Pharm Stat. 2020 Jul;19(4):436-453. doi: 10.1002/pst.2004. Epub 2020 Feb 18.
9
Restricted mean survival time for interval-censored data.有删失数据的限定平均生存时间。
Stat Med. 2020 Nov 20;39(26):3879-3895. doi: 10.1002/sim.8699. Epub 2020 Aug 7.
10
Performance of Restricted Mean Survival Time Based Methods and Traditional Survival Methods: An Application in an Oncological Data.基于受限平均生存时间的方法与传统生存方法的性能比较:在肿瘤学数据中的应用。
Comput Math Methods Med. 2022 Dec 28;2022:7264382. doi: 10.1155/2022/7264382. eCollection 2022.

本文引用的文献

1
Projection Test for Mean Vector in High Dimensions.高维均值向量的投影检验
J Am Stat Assoc. 2024;119(545):744-756. doi: 10.1080/01621459.2022.2142592. Epub 2022 Dec 12.
2
General independent censoring in event-driven trials with staggered entry.具有交错入组的事件驱动试验中的一般独立censoring。
Biometrics. 2023 Sep;79(3):1737-1748. doi: 10.1111/biom.13710. Epub 2022 Jul 19.
3
On the empirical choice of the time window for restricted mean survival time.限制平均生存时间的时间窗口的经验选择。
Biometrics. 2020 Dec;76(4):1157-1166. doi: 10.1111/biom.13237. Epub 2020 Feb 26.
4
A permutation test based on the restricted mean survival time for comparison of net survival distributions in non-proportional excess hazard settings.基于受限平均生存时间的排列检验,用于比较非比例超风险环境下的净生存分布。
Stat Methods Med Res. 2020 Jun;29(6):1612-1623. doi: 10.1177/0962280219870217. Epub 2019 Aug 28.
5
A flexible and coherent test/estimation procedure based on restricted mean survival times for censored time-to-event data in randomized clinical trials.一种基于受限平均生存时间的灵活一致的测试/估计程序,用于随机临床试验中删失的生存时间数据。
Stat Med. 2018 Jul 10;37(15):2307-2320. doi: 10.1002/sim.7661. Epub 2018 Apr 22.
6
Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time-to-event end point.在具有事件发生时间终点的优效性试验中,受限平均生存时间与风险比的比较。
Pharm Stat. 2018 May;17(3):202-213. doi: 10.1002/pst.1846. Epub 2017 Dec 28.
7
Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio.使用受限平均生存时间替代风险比来解释癌症临床试验结果的可解释性。
JAMA Oncol. 2017 Dec 1;3(12):1692-1696. doi: 10.1001/jamaoncol.2017.2797.
8
Efficiency of two sample tests via the restricted mean survival time for analyzing event time observations.通过受限平均生存时间进行两样本检验以分析事件时间观测值的效率
Biometrics. 2018 Jun;74(2):694-702. doi: 10.1111/biom.12770. Epub 2017 Sep 12.
9
On the restricted mean survival time curve in survival analysis.生存分析中受限平均生存时间曲线的研究
Biometrics. 2016 Mar;72(1):215-21. doi: 10.1111/biom.12384. Epub 2015 Aug 24.
10
A versatile test for equality of two survival functions based on weighted differences of Kaplan-Meier curves.一种基于Kaplan-Meier曲线加权差异的用于检验两个生存函数是否相等的通用方法。
Stat Med. 2015 Dec 10;34(28):3680-95. doi: 10.1002/sim.6591. Epub 2015 Jul 20.